The efficacy and safety of pyrotinib in treating HER2-positive metastatic breast cancer patients: a multicenter study
INTRODUCTION: To evaluate the clinical outcomes and safety profile of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients. MATERIAL AND METHODS: This is a multicenter retrospective study. Eligible enrolled HER2-positive MBC patients who received pyrotinib-containing regimens were incl...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Via Medica
2026-07-01
|
| coleção: | Oncology in Clinical Practice |
| Assuntos: | |
| Acesso em linha: | https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105828 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|